Raja Shekhar Nunavath
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Raja Shekhar Nunavath has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Krishnaveni Nagappan
Department of Pharmaceutical Analysis, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Ooty, The Nilgiris, Tamil Nadu, India
1 shared publication- Krishnaveni Nagappan
Department of Pharmaceutical Analysis, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Ooty, Nilgiris, India
1 shared publication Manoj Kumar T.
Department of Pharmaceutical Analysis, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Ooty, The Nilgiris, Tamil Nadu, India
1 shared publicationPreethi B.
Department of Pharmaceutical Analysis, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Ooty, The Nilgiris, Tamil Nadu, India
1 shared publication- Tejasree Thutkur
JSS Acad Higher Educ & Res, JSS Coll Pharm, Dept Pharmaceut Anal, The Nilgiris, Tamil Nadu, India
1 shared publication
Latest Publications
- Open Access
- 21 May 2024
- Published by SAGE Publications in Journal of Pharmacology and Pharmacotherapeutics
- Vol. 15 (2) , 142-152
Future of Pharmaceutical Industry: Role of Artificial Intelligence, Automation and Robotics
Background: The future of smart factories and pharmaceutical industries has evolved significantly since the 19th century. Computers have been used in the pharmaceutical field since the 1980s with the emergence of Artificial Intelligence (AI). In addition, automation and robotics are used in the pharmaceutical industry to improve the efficiency of pharmaceutical development and production.Purpose: The present review article covers the future roles of AI, automation and robotics in pharmaceutical industries.Methodology: The current review article employed a comprehensive search strategy across relevant databases, including PubMed, Scopus and Web of Science, utilizing keywords such as AI, Automation, Robotics and Pharmaceutical Industries. The articles considered a focus on recent advancements and emerging trends in the intersection of AI, automation and robotics within pharmaceutical sectors.Results: AI, incorporating predictive machine learning and reasoning techniques, aids in the preclinical identification of molecules and forecasting potential lead compounds before conducting clinical trials. automation offers significant benefits in monitoring and predictive maintenance of production lines, power distribution and control machines. Robotic process automation improves efficiency by connecting computer terminals to handle various manufacturing process elements.Conclusion: Artificial intelligence, automation and Robotics have sparked innovations in the healthcare business, benefiting the global ecosystem and healthcare delivery. Incorporating these advanced tools in pharmaceutical industries from raw material selection to final product development could improve the quality and safety of the pharmaceutical products and reduce the time and cost.
- 21 May 2024
- Published by SAGE Publications in Journal of Pharmacology and Pharmacotherapeutics
- Vol. 15 (2) , 142-152
Open AccessFuture of Pharmaceutical Industry: Role of Artificial Intelligence, Automation and Robotics
Background: The future of smart factories and pharmaceutical industries has evolved significantly since the 19th century. Computers have been used in the pharmaceutical field since the 1980s with the emergence of Artificial Intelligence (AI). In addition, automation and robotics are used in the pharmaceutical industry to improve the efficiency of pharmaceutical development and production.Purpose: The present review article covers the future roles of AI, automation and robotics in pharmaceutical industries.Methodology: The current review article employed a comprehensive search strategy across relevant databases, including PubMed, Scopus and Web of Science, utilizing keywords such as AI, Automation, Robotics and Pharmaceutical Industries. The articles considered a focus on recent advancements and emerging trends in the intersection of AI, automation and robotics within pharmaceutical sectors.Results: AI, incorporating predictive machine learning and reasoning techniques, aids in the preclinical identification of molecules and forecasting potential lead compounds before conducting clinical trials. automation offers significant benefits in monitoring and predictive maintenance of production lines, power distribution and control machines. Robotic process automation improves efficiency by connecting computer terminals to handle various manufacturing process elements.Conclusion: Artificial intelligence, automation and Robotics have sparked innovations in the healthcare business, benefiting the global ecosystem and healthcare delivery. Incorporating these advanced tools in pharmaceutical industries from raw material selection to final product development could improve the quality and safety of the pharmaceutical products and reduce the time and cost.